logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
L

lung cancer: targets and therapy

IF
Papers10
Citations
Journal Papers 12
Publication Date
delete
Sunvozertinib in EGFR Exon 20 Insertion NSCLC: Approved but Not Available – Practical Dose Selection Considerations and Real-World Access Challenges
deletelung cancer: targets and therapy
IF0
delete2026-05-28
delete0
deleteOAAI
deleteKim Abbegail Tan Aldecoa; Zhaohui Liao Arter; Sai-Hong Ignatius Ou; Misako Nagasaka
deleteShare
deleteSave
HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib – A Case Report
deletelung cancer: targets and therapy
IF0
delete2026-05-14
delete0
deleteOAAI
deleteMisako Nagasaka; Zhaohui L Arter; Cathleen J Park; Akshat Sarkari; Sai-Hong Ignatius Ou
deleteShare
deleteSave
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based <em>MET</em> Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer
deletelung cancer: targets and therapy
IF0
delete2026-05-08
delete0
deleteOAAI
deleteSi-Yang Maggie Liu; Zhi Xie; Lixu Yan; Guang-Ling Jie; Jia-Yi Deng; Qingling Zhang; Zhan Huang; Jin Wang; Zhou Zhang; Yang Shao; Hao Meng; Yan Zhang; Xu-Chao Zhang; Hua-Jun Chen; Wen-Zhao Zhong; Qing Zhou; Yi-Long Wu
deleteShare
deleteSave
Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China
deletelung cancer: targets and therapy
IF0
delete2026-02-18
delete0
deleteOAAI
deleteJianying Zhou; Yongsheng Wang; Jiewen Peng; Ke-Jing Tang; Jun Wu; Yajuan Chen; Zhiyi Xue; Yi-Long Wu
deleteShare
deleteSave
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer
deletelung cancer: targets and therapy
IF0
delete2026-01-06
delete0
deleteOAAI
deleteNina Schraps; Martin Reck; Birgit Hantzsch-Kuhn; Till Olchers; David Benjamin Ellebrecht; Katharina Möller; Christoph Fraune; Maximilian Lennartz; Florian Lutz; Martina Kluth; Georgia Makrypidi-Fraune; Ronald Simon; Guido Sauter; Stefan Steurer; Sönke Von Weihe
deleteShare
deleteSave
Incretin Receptor Agonist; Semaglutide; as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
deleteLung Cancer: Targets and Therapy
IF0
delete2025-12-25
delete0
deleteOAAI
deleteAlexandria TM Lee; Cathleen June Park; Zhaohui Liao Arter; Misako Nagasaka; Sai-Hong Ignatius Ou
deleteShare
deleteSave
Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC &ndash; Insights From Genomics; Proteomics; and Metabolomics
deleteLung Cancer: Targets and Therapy
IF0
delete2025-12-16
delete0
deleteOAAI
deleteEman Elayeh; Shereen M Aleidi; Orwa Aboud; Mohammad H Semreen; Yasser K Bustanji; Lina A Dahabiyeh
deleteShare
deleteSave
Pulmonary Nodular Lymphoid Hyperplasia: Reviewing a Lung Cancer Mimicker
deleteLung Cancer: Targets and Therapy
IF0
delete2025-12-10
delete0
deleteOAAI
deleteGabriela Schneider Galvão; Jônatas Fávero Prietto dos Santos; Ying-Han R Hsu; Patrik Rogalla
deleteShare
deleteSave
A Concise Review of the Approved MET TKIs (Savolitinib; Gumarontinib; Vebreltinib; Tepotinib; Capmatinib) in China for <em>MET</em> Exon 14 Splice Site Mutated (<em>METex14+</em>) NSCLC Circa 2025
deleteLung Cancer: Targets and Therapy
IF0
delete2025-10-31
delete0
deleteOAAI
deleteYanyan Hu; Sai-Hong Ignatius Ou
deleteShare
deleteSave
Successful and On-going Long-Term Disease Control (&gt;24 Months) with Gilteritinib in an <em>ALK+</em> NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib
deleteLung Cancer: Targets and Therapy
IF0
delete2025-10-22
delete0
deleteOAAI
deleteSai-Hong Ignatius Ou; Cathleen June Park; Zhaohui Liao Arter; Misako Nagasaka
deleteShare
deleteSave
Tumor Heterogeneity and Plasticity in Small Cell Lung Cancer
deleteLung Cancer: Targets and Therapy
IF0
delete2025-10-10
delete0
deleteOAAI
deleteGina N Duronio, Julien Sage
deleteShare
deleteSave
Emerging Targets in Non-Small Cell Lung Cancer
deleteLung Cancer: Targets and Therapy
IF0
delete2025-09-06
delete0
deleteOAAI
deleteJing Wang, Layana Biglow, Megan Baumgart
deleteShare
deleteSave